GATAD2B

Transcriptional repressor p66-beta · Q8WXI9 · GATAD2B on Sugi Atlas →

0 patent compounds predicted against GATAD2B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GATAD2B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA PHASE4COMPLETED
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations PHASE2RECRUITING
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC PHASE2COMPLETED
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients PHASE2COMPLETED
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag PHASE1/PHASE2COMPLETED
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment PHASE2COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
Natural History Study of GATA2 Deficiency and Related Disorders nanRECRUITING
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors nanUNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches. nanRECRUITING
Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients nanNOT_YET_RECRUITING
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea nanRECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
RORC Genetic Polymorphism of Rheumatoid Arthritis nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
DNA Methylation and Autoimmune Thyroid Diseases nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Family Resilience Initiative Research Program nanUNKNOWN
Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C nanCOMPLETED
Gene Expression and DNA Variation Analysis of Sacs to Identify the Pathophysiology of Indirect Inguinal Hernia nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a GATAD2B binder may also engage these)

ProteinNameSimilarity
Q8VHR5 1.000 Q8VHR5 →
GATAD2A Transcriptional repressor p66-alpha 0.994 landscape →
Q8CHY6 0.990 Q8CHY6 →
Q9P2N5 0.985 Q9P2N5 →
Q5SFM8 0.982 Q5SFM8 →
Q5R9C9 0.981 Q5R9C9 →
A0JNC2 0.980 A0JNC2 →
P17544 0.980 P17544 →
Q01826 0.978 Q01826 →
Q80TM6 0.978 Q80TM6 →
Q5T5P2 0.977 Q5T5P2 →
Q60611 0.977 Q60611 →
A2AQ25 0.977 A2AQ25 →
Q8NEM7 0.977 Q8NEM7 →
Q8VHG2 0.977 Q8VHG2 →
Q9HCE3 0.977 Q9HCE3 →
Q15032 0.976 Q15032 →
Q9UBL0 0.975 Q9UBL0 →
P16951 0.975 P16951 →
Q8CI08 0.975 Q8CI08 →
Q9DCB4 0.975 Q9DCB4 →
Q8R0S1 0.974 Q8R0S1 →
Q9Y2K5 0.974 Q9Y2K5 →
Q9P270 0.974 Q9P270 →
P15336 0.974 P15336 →
Q9NPI6 0.974 Q9NPI6 →
Q8VCB2 0.974 Q8VCB2 →
Q921D9 0.973 Q921D9 →
O09000 0.973 O09000 →
O14503 0.973 O14503 →